
Carlyle Group Inc.
About Carlyle Group Inc.’s 13F portfolio
Carlyle Group Inc. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Carlyle Group Inc. reported $10.0B across 19 US-listed positions (). Its largest position is Medline Inc (MDLN) at 74% of the reported book, and its ten biggest holdings make up 100% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: MDLN Medline Inc | $39.16 +3.93% | 74% | 187.1M | $7.4B |
| 2 | NYSE: SARO Standardaero Inc | $27.31 −0.26% | 25% | 84.6M | $2.5B |
| 3 | NASDAQ: PHAT Phathom Pharmaceuticals Inc | $5.30 −3.64% | 0.4% | 3.5M | $37.9M |
| 4 | NYSE: INVH Invitation Homes Inc | $26.44 −1.05% | 0.2% | 663K | $20.0M |
| 5 | NASDAQ: PONY Pony Ai Inc | $3.70 −7.27% | 0.2% | 2.4M | $16.4M |
| 6 | NYSE: GETY Getty Images Holdings Inc | $0.02 +1.19% | 0.1% | 6.2M | $5.4M |
| 7 | NASDAQ: SPRB Spruce Biosciences Inc | $40.84 +0.86% | 0.0% | 39K | $2.1M |
| 8 | NASDAQ: SPWR SunPower Inc | $4.19 +4228.51% | 0.0% | 2.3M | $1.6M |
| 9 | NASDAQ: ACET Adicet Bio Inc | $2.50 −10.07% | 0.0% | 184K | $1.6M |
| 10 | NASDAQ: FWRD Forward Air Corp | $17.37 −1.31% | 0.0% | 107K | $1.4M |
| 11 | NASDAQ: OKUR Onkure Therapeutics Inc | $2.82 +9.30% | 0.0% | 270K | $1.2M |
| 12 | NASDAQ: DNUT Krispy Kreme Inc | $3.47 −3.07% | 0.0% | 341K | $1.2M |
| 13 | NASDAQ: QTTB Q32 Bio Inc | $8.53 −1.16% | 0.0% | 60K | $769K |
| 14 | NYSE American: REPX Riley Exploration Permian In | $40.96 −4.19% | 0.0% | 16K | $530K |
| 15 | NASDAQ: NBIS Nebius Group N.V. | $106.96 +0.87% | 0.0% | 2K | $510K |
| 16 | NASDAQ: HOOD Robinhood Mkts Inc | $69.17 −0.03% | 0.0% | 5K | $475K |
| 17 | NASDAQ: JSPR Jasper Therapeutics Inc | $11.52 +11.41% | 0.0% | 1.1M | $449K |
| 18 | NYSE: NABL N-able Inc | $4.76 +1.28% | 0.0% | 94K | $344K |
| 19 | NASDAQ: METC Ramaco Res Inc | $6.03 +1.17% | 0.0% | 22K | $288K |
Showing the 19 largest positions reported in this 13F.
- Healthcare74%
- Industrials25%
- Real Estate0.2%
- Technology0.2%
- Communication Services0.1%
- Consumer Defensive0.0%
- Energy0.0%
- Financial Services0.0%
- Basic Materials0.0%
- AddedSPWRSunPower Inc+441%$1.6M
- NewREPXRiley Exploration Permian In—$530K
- NewNBISNebius Group N.V.—$510K
- AddedHOODRobinhood Mkts Inc+40.2%$475K
- NewMETCRamaco Res Inc—$288K
- ReducedINVHInvitation Homes Inc−0.2%$20.0M
- ReducedQTTBQ32 Bio Inc−94.5%$769K
- SoldXCURExicure Inc−100%—
- SoldHTFLHeartflow Inc−100%—
- SoldCUBECubeSmart−100%—
- SoldSYRESpyre Therapeutics Inc−100%—
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | SARO StandardAero, Inc. | 13G | 45.6% · 2 classes | 152.7M | Filed 12 AUG 2025 |
| 2 | MDLN Medline Inc. | 13G | 24.4% · 2 classes | 215.3M | Filed 13 FEB 2026 |
| 3 | CG The Carlyle Group Inc. | 13G | 8.1% · 2 classes | 29.2M | Filed 17 APR 2025 |
| 4 | SPWR SunPower Inc. | 13G | 5.4% | 6.4M | Filed 13 FEB 2026 |
Showing all 4 disclosed stakes. 2 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading Carlyle Group Inc.’s 13F portfolio
Carlyle Group Inc.’s $10.0B 13F book is spread across 19 reported positions and is highly concentrated — its ten largest positions alone are 100% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are MDLN, SARO, PHAT, INVH and PONY, led by Medline Inc (MDLN) at 74% of the portfolio. The heaviest sector exposure is Healthcare (74%), then Industrials (25%).
What Carlyle Group Inc. changed last quarter
Between 2026-03-31 and Q2 2026, Carlyle Group Inc. was a net seller: it opened 3 new positions and added to 2 more, while trimming 2 and closing 4 outright. Against a 19-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was SunPower Inc (SPWR), and its biggest reduction was Invitation Homes Inc (INVH).
What a 13F does and doesn’t reveal
A 13F captures only Carlyle Group Inc.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Carlyle Group Inc. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Carlyle Group Inc.'s profile on this page is built directly from those filings.
How current is the 13F data on Carlyle Group Inc.'s page?
It reflects Carlyle Group Inc.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Carlyle Group Inc. files its next quarterly report, this page refreshes automatically.
Can I see Carlyle Group Inc.'s complete list of holdings?
This page highlights Carlyle Group Inc.'s largest positions rather than all 19 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Carlyle Group Inc.'s filings.
Does a 13F show everything Carlyle Group Inc. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Carlyle Group Inc.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Carlyle Group Inc. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

